<p>藍鳥公司（NASDAQ:BLBD - 獲取免費報告）在週一發佈給客户和投資者的研究報告中，被 Zacks Research 的股票分析師將評級從 “持有” 下調至 “強烈賣出”，Zacks.com 報道。</p>
<ul>
<li>對於看漲投資者的前三大高風險高回報投資</li>
</ul>
<p>其他一些分析師最近也對 BLBD 發表了評論。華爾街 Zen 在 2 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “買入”。Needham &amp; Company LLC 在 5 月 7 日的研究報告中將藍鳥的目標價格從 78.00 美元上調至 86.00 美元，並給予該公司 “買入” 評級。BTIG Research 在 5 月 7 日的研究報告中將藍鳥的目標價格從 65.00 美元上調至 80.00 美元，並給予該股票 “買入” 評級。Freedom Capital 在 5 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “持有”。最後，巴克萊在 5 月 7 日的研究報告中將藍鳥的目標價格從 55.00 美元上調至 75.00 美元，並給予該股票 “超配” 評級。六位股票研究分析師對該股票給予了 “買入” 評級，一位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat 的數據，該股票的平均評級為 “適度買入”，共識目標價格為 75.80 美元。</p>
<p><strong>查看我們對藍鳥的最新股票分析</strong></p>
<h2>藍鳥股價下跌 1.5%</h2>
<ul>
<li>CRISPR Therapeutics 是基因編輯領域的 NVIDIA 嗎？</li>
</ul>
<p>NASDAQ:BLBD 週一開盤價為 69.33 美元。該公司的市值為 21.9 億美元，市盈率為 17.03，PEG 比率為 0.99，貝塔值為 1.38。該公司的流動比率為 1.83，速動比率為 1.27，債務與股本比率為 0.28。該股票的 50 日簡單移動平均線為 59.72 美元，200 日簡單移動平均線為 54.84 美元。藍鳥的 12 個月低點為 37.68 美元，12 個月高點為 81.51 美元。</p>
<p>藍鳥（NASDAQ:BLBD - 獲取免費報告）最後一次公佈季度財報是在 5 月 6 日，報告顯示該季度每股收益為 1.00 美元，超出分析師一致預期的 0.88 美元，超出幅度為 0.12 美元。藍鳥的股本回報率為 53.68%，淨利潤率為 8.91%。該公司該季度的收入為 3.5264 億美元，而分析師預期為 3.3523 億美元。在去年同期，該公司每股收益為 0.96 美元。藍鳥的季度收入同比下降了 1.7%。股票分析師預計藍鳥在當前年度將發佈 4.35 美元的每股收益。</p>
<h2>內部人員買賣情況</h2>
<ul>
<li>基因療法：為什麼單次治療要花費數百萬？</li>
</ul>
<p>在其他新聞中，首席財務官 Razvan Radulescu 在 2 月 19 日的交易中出售了 3,925 股藍鳥股票，交易價格為每股 60.98 美元，總價值為 239,346.50 美元。交易完成後，首席財務官持有該公司 42,255 股股票，價值約為 2,576,709.90 美元。此次交易代表其持股比例下降了 8.50%。該出售在向證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站訪問。此外，首席運營官 Jeffrey Scott Sanfrey 在 3 月 4 日的交易中出售了 5,192 股藍鳥股票，交易價格為每股 58.54 美元，總價值為 303,939.68 美元。交易完成後，首席運營官持有該公司 39,011 股股票，價值約為 2,283,703.94 美元。此次交易代表其持股比例下降了 11.75%。該出售的 SEC 文件提供了更多信息。1.10% 的股票由公司內部人員持有。</p>
<h2>機構資金流入和流出</h2>
<p>對沖基金最近對該公司的持倉進行了調整。Caitong International Asset Management Co. Ltd 在第三季度將其在藍鳥的持股增加了 10,028.6%。Caitong International Asset Management Co. Ltd 現在擁有 709 股該公司的股票，價值 41,000 美元，此前在上個季度購買了 702 股。洛克菲勒資本管理公司在第四季度將其在藍鳥的持股增加了 210.0%。洛克菲勒資本管理公司現在擁有 775 股該公司的股票，價值 36,000 美元，此前在上個季度增加了 525 股。Transamerica Financial Advisors LLC 在第四季度將其在藍鳥的持股增加了 222.7%。Transamerica Financial Advisors LLC 現在擁有 823 股該公司的股票，價值 39,000 美元，此前在上個季度增加了 568 股。Aster Capital Management DIFC Ltd 在第四季度獲得了藍鳥的一個新頭寸，價值 41,000 美元。最後，Larson Financial Group LLC 在第三季度將其在藍鳥的持股增加了 1,742.3%。Larson Financial Group LLC 現在擁有 1,308 股該公司的股票，價值 75,000 美元，此前在該期間購買了 1,237 股。機構投資者和對沖基金持有該公司 93.59% 的股票。</p>
<h2>藍鳥公司簡介</h2>
<p>（獲取免費報告）</p>
<p>藍鳥公司（NASDAQ: BLBD）是一家總部位於喬治亞州福特谷的領先公交車和公共交通工具製造商。公司的核心業務包括設計、工程和生產校車和活動巴士，產品線包括常規（C 型）車型、公交風格（D 型）車型以及特殊需求和活動運輸的特殊配置。近年來，藍鳥擴展了其產品，推出了零排放電動校車，體現了其對先進推進技術和環境可持續性的承諾。</p>
<p>藍鳥成立於 1927 年，在學生交通運輸領域建立了安全和可靠的聲譽。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票而非 Blue Bird</li>
<li>海軍催化劑點燃 Odysight 的增長引擎</li>
<li>AST SpaceMobile 因銀河 Q1 業績不佳暴跌：垂直整合能拯救這家 SpaceX 競爭對手嗎？</li>
<li>Axon 在財報發佈後大漲，但仍比高點下跌超過 50%</li>
<li>可能重新定義蘋果夏季反彈的事件</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 $1,000 在 Blue Bird 嗎？</h2>
<p>在你考慮 Blue Bird 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Blue Bird 並不在名單上。</p>
<p>雖然 Blue Bird 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

BLBD

<p>Zacks Research 將 Blue Bird（NASDAQ:BLBD）的評級從 “持有” 下調至 “強烈賣出”。其他分析師也調整了他們的評級，Wall Street Zen 將其下調至 “買入”，Needham & Company 則將目標價上調至 86 美元。Blue Bird 的股票共識評級為 “適度買入”，目標價為 75.80 美元。該股票開盤價為 69.33 美元，市值為 21.9 億美元。近期有內部人士出售股票的報告，且對沖基金已增加在該公司的持倉</p>

<p>Blue Bird (NASDAQ:BLBD - Get Free Report) was downgraded by stock analysts at Zacks Research from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report issued to clients and investors on Monday,Zacks.com reports.</p>
<div class="lb-trans"><p>藍鳥公司（NASDAQ:BLBD - 獲取免費報告）在週一發佈給客户和投資者的研究報告中，被 Zacks Research 的股票分析師將評級從 “持有” 下調至 “強烈賣出”，Zacks.com 報道。</p>
</div><ul>
<li>Top 3 High-Risk, High-Reward Plays for Bullish Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>對於看漲投資者的前三大高風險高回報投資</li>
</ul>
</div><p>A number of other analysts also recently commented on BLBD. Wall Street Zen downgraded Blue Bird from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, February 7th. Needham &amp; Company LLC upped their price objective on Blue Bird from $78.00 to $86.00 and gave the company a &#34;buy&#34; rating in a research report on Thursday, May 7th. BTIG Research increased their target price on Blue Bird from $65.00 to $80.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, May 7th. Freedom Capital downgraded Blue Bird from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, May 7th. Finally, Barclays upped their price target on Blue Bird from $55.00 to $75.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $75.80.</p>
<div class="lb-trans"><p>其他一些分析師最近也對 BLBD 發表了評論。華爾街 Zen 在 2 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “買入”。Needham &amp; Company LLC 在 5 月 7 日的研究報告中將藍鳥的目標價格從 78.00 美元上調至 86.00 美元，並給予該公司 “買入” 評級。BTIG Research 在 5 月 7 日的研究報告中將藍鳥的目標價格從 65.00 美元上調至 80.00 美元，並給予該股票 “買入” 評級。Freedom Capital 在 5 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “持有”。最後，巴克萊在 5 月 7 日的研究報告中將藍鳥的目標價格從 55.00 美元上調至 75.00 美元，並給予該股票 “超配” 評級。六位股票研究分析師對該股票給予了 “買入” 評級，一位給予了 “持有” 評級，一位給予了 “賣出” 評級。根據 MarketBeat 的數據，該股票的平均評級為 “適度買入”，共識目標價格為 75.80 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Blue Bird</strong></p>
<div class="lb-trans"><p><strong>查看我們對藍鳥的最新股票分析</strong></p>
</div><h2>Blue Bird Trading Down 1.5%</h2>
<div class="lb-trans"><h2>藍鳥股價下跌 1.5%</h2>
</div><ul>
<li>Is CRISPR Therapeutics the NVIDIA of gene editing?</li>
</ul>
<div class="lb-trans"><ul>
<li>CRISPR Therapeutics 是基因編輯領域的 NVIDIA 嗎？</li>
</ul>
</div><p>NASDAQ:BLBD opened at $69.33 on Monday. The firm has a market cap of $2.19 billion, a P/E ratio of 17.03, a PEG ratio of 0.99 and a beta of 1.38. The company has a current ratio of 1.83, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28. The stock's 50 day simple moving average is $59.72 and its 200-day simple moving average is $54.84. Blue Bird has a 12-month low of $37.68 and a 12-month high of $81.51.</p>
<div class="lb-trans"><p>NASDAQ:BLBD 週一開盤價為 69.33 美元。該公司的市值為 21.9 億美元，市盈率為 17.03，PEG 比率為 0.99，貝塔值為 1.38。該公司的流動比率為 1.83，速動比率為 1.27，債務與股本比率為 0.28。該股票的 50 日簡單移動平均線為 59.72 美元，200 日簡單移動平均線為 54.84 美元。藍鳥的 12 個月低點為 37.68 美元，12 個月高點為 81.51 美元。</p>
</div><p>Blue Bird (NASDAQ:BLBD - Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.00 earnings per share for the quarter, topping analysts' consensus estimates of $0.88 by $0.12. Blue Bird had a return on equity of 53.68% and a net margin of 8.91%.The firm had revenue of $352.64 million for the quarter, compared to analyst estimates of $335.23 million. During the same quarter in the prior year, the company posted $0.96 earnings per share. Blue Bird's quarterly revenue was down 1.7% on a year-over-year basis. Equities analysts anticipate that Blue Bird will post 4.35 EPS for the current year.</p>
<div class="lb-trans"><p>藍鳥（NASDAQ:BLBD - 獲取免費報告）最後一次公佈季度財報是在 5 月 6 日，報告顯示該季度每股收益為 1.00 美元，超出分析師一致預期的 0.88 美元，超出幅度為 0.12 美元。藍鳥的股本回報率為 53.68%，淨利潤率為 8.91%。該公司該季度的收入為 3.5264 億美元，而分析師預期為 3.3523 億美元。在去年同期，該公司每股收益為 0.96 美元。藍鳥的季度收入同比下降了 1.7%。股票分析師預計藍鳥在當前年度將發佈 4.35 美元的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部人員買賣情況</h2>
</div><ul>
<li>Gene therapy: Why does it cost millions for a single treatment?</li>
</ul>
<div class="lb-trans"><ul>
<li>基因療法：為什麼單次治療要花費數百萬？</li>
</ul>
</div><p>In other news, CFO Razvan Radulescu sold 3,925 shares of Blue Bird stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $60.98, for a total value of $239,346.50. Following the completion of the transaction, the chief financial officer owned 42,255 shares in the company, valued at approximately $2,576,709.90. This trade represents a 8.50% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, COO Jeffrey Scott Sanfrey sold 5,192 shares of Blue Bird stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $58.54, for a total value of $303,939.68. Following the completion of the transaction, the chief operating officer owned 39,011 shares of the company's stock, valued at approximately $2,283,703.94. The trade was a 11.75% decrease in their position. The SEC filing for this sale provides additional information. 1.10% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他新聞中，首席財務官 Razvan Radulescu 在 2 月 19 日的交易中出售了 3,925 股藍鳥股票，交易價格為每股 60.98 美元，總價值為 239,346.50 美元。交易完成後，首席財務官持有該公司 42,255 股股票，價值約為 2,576,709.90 美元。此次交易代表其持股比例下降了 8.50%。該出售在向證券交易委員會的法律文件中披露，相關信息可通過 SEC 網站訪問。此外，首席運營官 Jeffrey Scott Sanfrey 在 3 月 4 日的交易中出售了 5,192 股藍鳥股票，交易價格為每股 58.54 美元，總價值為 303,939.68 美元。交易完成後，首席運營官持有該公司 39,011 股股票，價值約為 2,283,703.94 美元。此次交易代表其持股比例下降了 11.75%。該出售的 SEC 文件提供了更多信息。1.10% 的股票由公司內部人員持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Blue Bird by 10,028.6% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company's stock worth $41,000 after purchasing an additional 702 shares during the last quarter. Rockefeller Capital Management L.P. raised its stake in Blue Bird by 210.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 775 shares of the company's stock valued at $36,000 after acquiring an additional 525 shares in the last quarter. Transamerica Financial Advisors LLC raised its stake in Blue Bird by 222.7% during the 4th quarter. Transamerica Financial Advisors LLC now owns 823 shares of the company's stock valued at $39,000 after acquiring an additional 568 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of Blue Bird during the 4th quarter valued at $41,000. Finally, Larson Financial Group LLC increased its position in shares of Blue Bird by 1,742.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,308 shares of the company's stock valued at $75,000 after purchasing an additional 1,237 shares during the period. Institutional investors and hedge funds own 93.59% of the company's stock.</p>
<div class="lb-trans"><p>對沖基金最近對該公司的持倉進行了調整。Caitong International Asset Management Co. Ltd 在第三季度將其在藍鳥的持股增加了 10,028.6%。Caitong International Asset Management Co. Ltd 現在擁有 709 股該公司的股票，價值 41,000 美元，此前在上個季度購買了 702 股。洛克菲勒資本管理公司在第四季度將其在藍鳥的持股增加了 210.0%。洛克菲勒資本管理公司現在擁有 775 股該公司的股票，價值 36,000 美元，此前在上個季度增加了 525 股。Transamerica Financial Advisors LLC 在第四季度將其在藍鳥的持股增加了 222.7%。Transamerica Financial Advisors LLC 現在擁有 823 股該公司的股票，價值 39,000 美元，此前在上個季度增加了 568 股。Aster Capital Management DIFC Ltd 在第四季度獲得了藍鳥的一個新頭寸，價值 41,000 美元。最後，Larson Financial Group LLC 在第三季度將其在藍鳥的持股增加了 1,742.3%。Larson Financial Group LLC 現在擁有 1,308 股該公司的股票，價值 75,000 美元，此前在該期間購買了 1,237 股。機構投資者和對沖基金持有該公司 93.59% 的股票。</p>
</div><h2>Blue Bird Company Profile</h2>
<div class="lb-trans"><h2>藍鳥公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Blue Bird Corporation NASDAQ: BLBD is a leading manufacturer of buses and mass transportation vehicles headquartered in Fort Valley, Georgia. The company's core business encompasses the design, engineering, and production of school buses and activity buses, with a product lineup that includes conventional (Type C) models, transit-style (Type D) models and specialty configurations for special-needs and activity transport. In recent years, Blue Bird has expanded its offerings to include zero-emission electric school buses, reflecting its commitment to advanced propulsion technologies and environmental sustainability.</p>
<div class="lb-trans"><p>藍鳥公司（NASDAQ: BLBD）是一家總部位於喬治亞州福特谷的領先公交車和公共交通工具製造商。公司的核心業務包括設計、工程和生產校車和活動巴士，產品線包括常規（C 型）車型、公交風格（D 型）車型以及特殊需求和活動運輸的特殊配置。近年來，藍鳥擴展了其產品，推出了零排放電動校車，體現了其對先進推進技術和環境可持續性的承諾。</p>
</div><p>Established in 1927, Blue Bird has built a legacy of safety and reliability in student transportation.</p>
<div class="lb-trans"><p>藍鳥成立於 1927 年，在學生交通運輸領域建立了安全和可靠的聲譽。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Blue Bird</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票而非 Blue Bird</li>
<li>海軍催化劑點燃 Odysight 的增長引擎</li>
<li>AST SpaceMobile 因銀河 Q1 業績不佳暴跌：垂直整合能拯救這家 SpaceX 競爭對手嗎？</li>
<li>Axon 在財報發佈後大漲，但仍比高點下跌超過 50%</li>
<li>可能重新定義蘋果夏季反彈的事件</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=BLBD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Blue Bird Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Blue Bird 嗎？</h2>
</div><p>Before you consider Blue Bird, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Blue Bird 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blue Bird wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Blue Bird 並不在名單上。</p>
</div><p>While Blue Bird currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Blue Bird 目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Blue Bird (NASDAQ:BLBD) 被 Zacks Research 下調至 “強烈賣出” 評級